A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials-Reference-Cited by-同舟云学术

A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials

Published:2021-05-01 Issue:3 Volume:3 Page:e210008
ISSN:2638-616X
Container-title:Radiology: Imaging Cancer
language:en
Short-container-title:Radiology: Imaging Cancer

Author:

Ruchalski Kathleen¹^ORCID,Braschi-Amirfarzan Marta¹,Douek Michael¹^ORCID,Sai Victor¹,Gutierrez Antonio¹^ORCID,Dewan Rohit¹,Goldin Jonathan¹

Affiliation:

1. From the Department of Radiological Sciences, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Suite 1621, Los Angeles, CA 90095-1721 (K.R., M.D., V.S., A.G., R.D., J.G.); and Department of Radiology, Beth Israel Lahey Health, Burlington, Mass (M.B.A.).

Funder

AUR-GE Radiology Research Academic Fellowship

Publisher

Radiological Society of North America (RSNA)

Subject

Religious studies,Cultural Studies

Link

http://pubs.rsna.org/doi/pdf/10.1148/rycan.2021210008

Reference41 articles.

1. Estimated costs of pivotal trials for U.S. Food and Drug Administration–approved cancer drugs, 2015–2017

2. Spending on new drug development

3. The Value of Improving the Productivity of the Drug Development Process

4. Review of Phase II Trial Designs Used in Studies of Molecular Targeted Agents: Outcomes and Predictors of Success in Phase III

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between pathologic response and survival after neoadjuvant therapy in lung cancer;Nature Medicine;2023-10-30

2. Overview of approaches to estimate real-world disease progression in lung cancer;JNCI Cancer Spectrum;2023-09-21

3. Incurable advanced salivary gland tumours: a retrospective analysis and peek into the perplexing clinical and molecular intricacies from a tertiary care centre in India;ecancermedicalscience;2023-09-21

4. Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches;Frontiers in Pharmacology;2023-03-08

5. Re-induction of avelumab for patients with metastatic merkel cell carcinoma;INDIAN J DERMATOL;2023